KRAS and colorectal carcinoma: To unmask the role of micro-environment-derived HGF in the response of CRC to AIs, we orthotopically injected human CRC cells bearing KRAS or BRAF mutations into wild-type (WT) and hHGF KI SCID mice, and compared the efficacy of different anti-angiogenic drugs in these two strains.